Clinical Trials Directory

Trials / Completed

CompletedNCT06611475

Prediction of MMSE Scores for Cognitive Impairment

Prediction of MMSE Scores for Cognitive Impairment: A Machine Learning Analysis of Oral Health and Demographic Data in Individuals Over 60 Years of Age

Status
Completed
Phase
Study type
Observational
Enrollment
693 (actual)
Sponsor
Blekinge Institute of Technology · Academic / Other
Sex
All
Age
60 Years
Healthy volunteers
Accepted

Summary

This study aims to explore the potential of using machine learning (ML) algorithms to predict cognitive status, specifically MMSE scores, based on oral health and demographic data. The objective is to evaluate the effectiveness of various ML models and identify the most relevant oral health indicators for predicting MMSE scores of 30 (normal cognition) or ≤26 (cognitive impairment) in individuals aged 60 and above.

Detailed description

This cross-sectional study utilizes oral health and demographic data from two existing cohort studies: the European collaborative study Support Monitoring and Reminder Technology for Mild Dementia (SMART4MD) and the Swedish National Study on Aging and Care (SNAC-B). Participants aged 60 years or older will be included in the analysis. The data will be used to develop and evaluate machine learning models for predicting cognitive status. Objectives: 1. Primary Objective: To assess the potential of oral health parameters for binary classification of MMSE scores (30 vs. ≤26). 2. Secondary Objective: To identify the most influential oral health parameters contributing to cognitive impairment predictions. 3. Tertiary Objective: To compare the performance of Random Forest (RF), Support Vector Machine (SVM), and CatBoost (CB) classifiers in predicting MMSE scores using oral health data.

Conditions

Interventions

TypeNameDescription
OTHERMMSE ≤26A dataset comprising participants with MMSE scores of ≤26 and 30 will be used to evaluate the classification performance of various machine learning techniques.

Timeline

Start date
2024-06-10
Primary completion
2024-10-10
Completion
2024-11-10
First posted
2024-09-25
Last updated
2024-11-25

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT06611475. Inclusion in this directory is not an endorsement.